The HPV Vaccine and Cervical Neoplasia: Not Just for Warts Anymore
Craig A. Elmets
Abstract
Craig A. Elmets
Abstract
Genital infection with human papillomavirus (HPV) is the etiologic agent for almost all cervical cancers; approximately 70% of cases involve HPV type 16 or 18. High-grade cervical lesions often begin to develop within 2 years of HPV infection. To determine whether a quadrivalent HPV vaccine (Gardasil) could prevent cervical intraepithelial neoplasia (CIN), investigators conducted a phase 3 trial in more than 10,000 women (age …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Genital infection with human papillomavirus (HPV) is the etiologic agent for almost all cervical cancers; approximately 70% of cases involve HPV type 16 or 18. High-grade cervical lesions often begin to develop within 2 years of HPV infection. To determine whether a quadrivalent HPV vaccine (Gardasil) could prevent cervical intraepithelial neoplasia (CIN), investigators conducted a phase 3 trial in more than 10,000 women (age …
Key concepts: Medicine, Gardasil, Genital warts, Cervical intraepithelial neoplasia, Cervical cancer, Human papillomavirus, HPV infection, HPV vaccines